Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Scientific Reports|February 3, 2016
Inhibition of lysosomal protease cathepsin D reduces renal fibrosis in murine chronic kidney diseaseChristopher Fox, Pasquale Cocchiaro, Fiona Oakley, et al.Journal of Hepatology|April 13, 2016
A new fluorescence-based optical imaging method to non-invasively monitor hepatic myofibroblasts in vivoSaimir Luli, Daniela Di Paolo, Patrizia Perri, et al.The Biochemical Journal|October 14, 2022
Claspin haploinsufficiency leads to defects in fertility, hyperplasia and an increased oncogenic potentialSuzanne Madgwick, Saimir Luli, Helene Sellier, et al.Journal of Hepatology|August 13, 2015
Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver diseaseCaroline L Wilson, Lindsay B Murphy, Jack Leslie, et al.Hepatology (Baltimore, Md.)|May 28, 2020
Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular CarcinomaZoe Hall, Davide Chiarugi, Evelina Charidemou, et al.The International Journal of Biochemistry & Cell Biology|December 27, 2019
Loss of ELK1 has differential effects on age-dependent organ fibrosisJennifer T Cairns, Anthony Habgood, Rochelle C Edwards-Pritchard, et al.Hepatology (Baltimore, Md.)|August 6, 2019
Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver DiseaseFrancesco De Chiara, Karen Louise Thomsen, Abeba Habtesion, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin AMüjdat Zeybel, Saimir Luli, Laura Sabater, et al.Hepatology (Baltimore, Md.)|July 7, 2021
A Mammalian Target of Rapamycin-Perilipin 3 (mTORC1-Plin3) Pathway is essential to Activate Lipophagy and Protects Against HepatosteatosisMarina Garcia-Macia, Adrián Santos-Ledo, Jack Leslie, et al.Hepatology Communications|May 16, 2025
Precision-cut tumor slices for modeling hepatocellular carcinoma enable at-scale drug screeningAmy L Collins, Keara Kirkness, Erik Ramon-Gil, et al.Pageof 5